Pediatr. praxi. 2023;24(6):385-388 | DOI: 10.36290/ped.2023.093

Enterobius vermicularis - vector of the difficult-to-diagnose intestinal trichomonad Dientamoeba fragilis?

Mgr. Hana Bílková Fránková, MBA
Oddělení klinické mikrobiologie, Laboratoře AGEL, a. s., Ostrava

Enterobius vermicularis (E. vermicularis) is currently the most common helminth of the human intestine. The statistics of the National Reference Laboratory for Intestinal Parasitoses show that it is almost the only representative of the helminth group in our conditions (1) (Table 1). Occurs or diagnoses this disease (enterobiosis, oxyuriasis) especially in children. Due to the rapid maturation of larvae in the egg (4-6 h), their overproduction (an adult female lays 5 000-12 000 eggs (2) (Fig. 1a, b, Fig. 2a, b) and the high resistance of eggs to external influences, I assume the current occurrence in most family members, including adults. Due to the relatively high prevalence of the pathogenic trichomonad Dientamoeba fragilis (D. fragilis) in stool samples of paediatric patients, I am inclined to the hypothesis, expressed already in 1940 by Dobell (3), that the roup may be the vector of their transmission and which is supported by e.g. Stark et al. (4) This is also suggested by the results of the study Prevalence and clinical significance of parasitic infections in the population of 0-15-year-old children in Ostrava region, which was carried out by our department together with the Children's Department of Vítkovice Hospital.Here, D. fragilis was present in 26,5 % of respondents, in 11% together with E. vermicularis (5). With the introduction of molecular biological diagnostic methods (RT PCR) into the routine practice of some laboratories in the Czech Republic, the number of their findings has increased significantly. Thus, D. fragilis has currently been leading in the NRL statistics for several years (11), (Table 2, 3). The mode of transmission is of interest to parasitologists (4, 5, 6, 7, 8). Stark et al. report the existence of precystic and cystic stages (9), but this remains a matter of professional debate.

Keywords: parazit, Dientamoeba fragilis, Enterobius vermicularis.

Accepted: November 14, 2023; Published: November 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bílková Fránková H. Enterobius vermicularis - vector of the difficult-to-diagnose intestinal trichomonad Dientamoeba fragilis?. Pediatr. praxi. 2023;24(6):385-388. doi: 10.36290/ped.2023.093.
Download citation

References

  1. Statistika parazitů v ČR. Available from: https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-HELM-za-rok-2018-1.pdf, https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-HELM-za-rok-2019-1.pdf, https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-HELM-za-rok-2020.pdf, https://www.zuusti.cz/wp-content/uploads/2022/04/nrl-helm-za-rok-2021.pdf, https://www.zuusti.cz/wp-content/uploads/2023/04/nrl-helm-za-rok-2022.pdf.
  2. Jírovec OJ. Parasitologie pro lékaře. Praha: Avicenum; 1977.
  3. Dobell C. Researches on the intestinal protozoa of monkeys and man. X. The life-history of Dientamoeba fragilis: observation, experiments, and speculations. Parasitology. 1940;32:417-461. Go to original source...
  4. Stark DJ, Beeden N, Marriott D et al. Dientamoebiasis. Clinical importence and recent advances. Trends parasitol. 2006;22:92-96. Go to original source... Go to PubMed...
  5. Bílková Fránková H, Boženský J, Mikošková A. Střevní parazité u dětí včera dnes i zítra. Pediatr. praxi. 2022;23:394-396. Go to original source...
  6. Barratt JL, Harkness J, Marriott D, et al. The ambiguous life of Dientamoeba fragilis. The need to investigative current hypotheses on transmision. Parasitology. 2011;138:557-576. Go to original source... Go to PubMed...
  7. Stark DJ, Beeden N, Marriott D, et al. Prospective study of the prevalence, genotyphing and clinical relevance of Dientamoeba fragilis infection in an australian population. J Clin Microbiol. 2015;43:2718-2723. Go to original source... Go to PubMed...
  8. Stark D, Barratt J, Chan D, et al. Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel. Clinical Microbiology Reviews. 2016; 29(3):553-580. Go to original source... Go to PubMed...
  9. Stark D, Garcia LS, Barratt JL, et al. Description of Dientamoeba fragilis cysts and precystic forms from human samples. J Clin Microbiol. 2014;52(7):2680-2683. Go to original source... Go to PubMed...
  10. Nohýnková E. Dientamoeba fragilis - opomíjený patogen lidského střeva. Seminář Oportunní a opomíjené protozoární střevní nákazy [online]. Praha: 2005;S:6-9. Available from: http://www.parazitologie.cz/protozoologie/SbornikLD05.pdf.
  11. Statistika parazitů v ČR. Available from: https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-PROTO-za-rok-2018-1.pdf, https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-PROTO-za-rok-2019-1.pdf, https://www.zuusti.cz/wp-content/uploads/2021/04/NRL-PROTO-za-rok-2020.pdf, https://www.zuusti.cz/wp-content/uploads/2022/04/NRL-PROTO-za-rok-2021.pdf, https://www.zuusti.cz/wp-content/uploads/2023/04/NRL-PROTO-za-rok-2022.pdf.
  12. Stejskal F. Současná léčba helmintóz. Klin farmakol Farm. 2005;19:111-115.
  13. Johnson EH, Windsor JJ, Clarck CG. Emerging of obscurity: Biological, clinical and diagnostics aspects of Dientamoeba fragilis. Clinical Microbiology Review. 2004;17:553-570. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.